Furthermore, RCC patients at stage T1/T2, stage T3/T4, N0, N1 and M0, but M1, in the low CRP/Alb group had significantly longer OS than their counterparts in the high CRP/Alb group (P < 0.001, P < 0.001, P < 0.001, P = 0.006 and P < 0.001, respectively). This evidence concerns the gene ALB and renal cell carcinoma.